Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: Incyte Corporation
Condition: Advanced Solid Tumors
NCT05949632
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
This was a strategic business decision. There were no safety concerns contributing to this decision.